Jeremy D. Daniel

Mr. Daniel, age 46, has served since 2019 as the Chief Financial Officer of H-CYTE, Inc. (“H-CYTE”), a public reporting hybrid biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization. From 2013 to 2019, Mr. Daniel served as Chief Financial Officer of Regenerative Medicine Solutions, LLC, which was acquired by H-CYTE in 2019. He currently serves on the Board of Directors of Medovex LLC, a subsidiary of H-CYTE. Mr. Daniel received his BS in Accounting from the University of Cincinnati and his MBA from Xavier University.
Sign up for our investor alerts
Select your notifications:
Miami Office
Alfi Inc. (Delaware Corporation)
429 Lenox Avenue, Suite 547 Miami Beach, Florida 33139 U.S.A
+1 (305) 395 4520
File Number: 6964750 (Delaware)
Belfast Office
Alfi (N.I.) LTD
City Exchange Building, 5th Floor 11-13 Gloucester Street, Belfast, BT14LS, UK
+44 (0)28 9600 2500
Company Number NI655794
Denver Office
Alfi Inc.
Triangle Building 1550 Wewatta Street
Denver, CO 80202 USA
+1 (305) 395 4520